ANANTHA SHEKHAR, M.D.
Psychiatric at University Blvd, Indianapolis, IN

License number
Indiana 01035378A
Category
Psychiatric
Type
Psychiatry
Address
Address
550 University Blvd, Indianapolis, IN 46202
Phone
(317) 274-8660
(317) 274-4402
(317) 278-1302 (Fax)

Personal information

See more information about ANANTHA SHEKHAR at radaris.com
Name
Address
Phone
Anantha Shekhar, age 67
4136 N Meridian St, Indianapolis, IN 46208
Anantha P Shekhar, age 67
7627 80Th St, Indianapolis, IN 46256
(317) 576-1985

Organization information

See more information about ANANTHA SHEKHAR at bizstanding.com

Anantha Shekhar MD,MBBS,BS

1700 N Illinois St, Indianapolis, IN 46202

Industry:
Psychiatrist
Phone:
(317) 554-5700 (Phone)
Anantha Shekhar

Professional information

Anantha Shekhar Photo 1

Dr. Anantha Shekhar, Indianapolis IN - MD (Doctor of Medicine)

Specialties:
Psychiatry, Neuropsychiatry (Psychiatry)
Address:
Indiana University Psychiatric
1111 W 10Th St, Indianapolis 46202
(317) 278-9100 (Phone)
550 University Blvd, Indianapolis 46202
(317) 274-8660 (Phone)
Midtown Adult Services PSY
1700 N Illinois St, Indianapolis 46202
(317) 554-5700 (Phone)
Certifications:
Psychiatry, 1994
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Indiana University Psychiatric
1111 W 10Th St, Indianapolis 46202
Midtown Adult Services PSY
1700 N Illinois St, Indianapolis 46202
550 University Blvd, Indianapolis 46202
Indiana University Health University Hospital
550 University Blvd, Indianapolis 46202
Education:
Medical School
Indiana University / School of Medicine
Ind University School Med Center
Graduated: 1985
Graduated: 1989


Anantha Shekhar Photo 2

Treatment Of Symptoms Associated With Menopause

US Patent:
2013019, Jul 25, 2013
Filed:
Sep 29, 2011
Appl. No.:
13/876053
Inventors:
Anantha Shekhar - Indianapolis IN, US
Philip L. Johnson - Indianapolis IN, US
Assignee:
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORA - INDIANAPOLIS IN
International Classification:
A61K 31/551, A61K 31/47, A61K 31/4375
US Classification:
800 9, 514300, 514218, 514307
Abstract:
A method for treating symptoms associated with a dramatic reduction in reproductive hormone levels is provided, particularly in menopausal women and breast cancer survivors undergoing aromatase inhibitor therapy. The method comprises administered to a subject an inhibitor of orexin activity in an amount sufficient to reduce or decrease onset, progression, severity, frequency, duration or probability of one or more such symptoms. A method of detecting compounds having activity for relieving menopausal symptoms is also provided.


Anantha Shekhar Photo 3

Treatment Of Glaucoma

US Patent:
2014003, Feb 6, 2014
Filed:
Mar 29, 2012
Appl. No.:
14/009294
Inventors:
Brian C. Samuels - Indianapolis IN, US
Anantha Shekhar - Indianapolis IN, US
Philip L. Johnson - Indianapolis IN, US
Assignee:
Indiana University Research and Technology Corporation - Indianapolis IN
International Classification:
A61K 31/4375
US Classification:
514300
Abstract:
A method is provided for treating patients suffering from elevated intraocular pressure or fluctuation in intraocular pressure, including for example glaucoma patients. The method comprises administering to the patient an inhibitor of orexin activity in an amount sufficient to reduce intraocular pressure or intraocular pressure fluctuation in one or both eyes of the patient.


Anantha Shekhar Photo 4

Methods And Compositions For Panic Disorders

US Patent:
2012026, Oct 25, 2012
Filed:
Oct 21, 2010
Appl. No.:
13/503609
Inventors:
Anantha Shekhar - Indianapolis IN, US
Philip L. Johnson - Indianapolis IN, US
Assignee:
INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION - Indianapolis IN
International Classification:
A61K 31/4375, A61K 31/472, A61K 31/4706, A61K 31/551, A61K 39/395, A61P 7/00, A61P 11/00, A61P 9/04, A61P 25/00, A61P 9/12, A61P 25/22, A61K 31/713, G01N 33/566
US Classification:
4241351, 514 44 A, 514307, 514300, 514313, 514218, 4241581, 436501
Abstract:
Methods and compositions that down regulate the activity of orexins to treat panic disorder and panic-like responses associated with hypercapnic conditions are disclosed.